Phase II trial of methylglyoxal-bis(guanylhydrazone) (MGBG) in patients with refractory multiple myeloma: an Eastern Cooperative Oncology Group (ECOG) study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples